Clinical Scorecard: Immunization Strategies for Heart Failure Patients in Clinical Settings
At a Glance
Category
Detail
Condition
Heart failure complicated by respiratory infections
Key Mechanisms
Systemic inflammation from respiratory pathogens triggers cardiovascular events and acute HF decompensation via pro-coagulant status and immune activation
Target Population
Patients with heart failure, especially those with pre-existing cardiovascular disease
Care Setting
Clinical outpatient and inpatient settings managing heart failure patients
Key Highlights
Respiratory infections (influenza, pneumococcus, SARS-CoV2, RSV) significantly increase risk of acute HF decompensation and mortality.
Vaccination coverage among HF patients remains low due to limited provider awareness and engagement.
ESC guidelines recommend influenza and pneumococcal vaccination to reduce respiratory infections and cardiovascular complications in HF.
Guideline-Based Recommendations
Diagnosis
Recognize respiratory infections as a primary cause of acute HF decompensation.
Assess vaccination status routinely in HF patients.
Management
Administer recommended vaccines including influenza, pneumococcal, COVID-19, and consider emerging vaccines for RSV.
Engage healthcare providers, especially cardiologists and general practitioners, in vaccination efforts.
Implement educational programs to increase vaccination awareness among providers and patients.
Monitoring & Follow-up
Monitor HF patients for signs of respiratory infections and acute decompensation.
Track vaccination coverage rates within HF populations to identify gaps.
Risks
Unvaccinated HF patients have higher risk of pneumonia, thrombotic events, arrhythmias, and mortality.
Heart failure patients with or without concomitant cardiovascular disease
Vaccination reduces incidence of respiratory infections, systemic inflammation, and acute HF episodes; however, vaccination rates remain suboptimal due to provider and patient barriers.
Clinical Best Practices
Incorporate vaccination status checks into routine HF patient assessments.
Educate healthcare providers on the importance of vaccines in preventing HF complications.
Promote multidisciplinary collaboration to improve vaccination uptake in HF patients.
Address patient concerns and misinformation regarding vaccines to enhance acceptance.
Follow ESC guidelines recommending influenza and pneumococcal vaccines for HF patients.
by François Roubille, Nicolas Chapet, Camille Roubille, Marc Villacèque, Clément Delmas, Muriel Salvat, Frédéric Mouquet, Thibaud Damy, Jean-Michel Tartiere, Emmanuelle Berthelot, Peter Libby, Gianluigi Savarese, Paul Loubet, Nicolas Girerd
